AI assistant
Sending…
Traws Pharma, Inc. — Director's Dealing 2016
Aug 11, 2016
35199_dirs_2016-08-10_e2451092-eda8-4e70-b172-f89925da473f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2016-06-29
Reporting Person: GROOPMAN JEROME (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-29 | Common Stock | M | 10 | $5.20 | Acquired | 10 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-29 | Stock Option (right to buy) | $5.20 | M | 10 | Disposed | 2026-05-18 | Common Stock (10) | Direct |
More from Traws Pharma, Inc.
Annual Report
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Share Issue/Capital Change
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 8